300677.SZ
英科医疗
SZSE · Healthcare · C 制造业 · CN
CNY 48.10
−0.64%Year over year
Reported trailing growth
- Revenue
- +5.1%
- EBITDA
- —
- EBIT
- -50.9%
- EPS
- -56.7%
- Free cash flow
- +23.8%
- Operating cash flow
- +33.7%
Forward estimates
Based on analyst estimates
- Revenue
- -61.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +14.5%
- EBITDA
- +18.1%
- EBIT
- +20.3%
- Net income
- +17.1%
- EPS
- +18.5%
- Free cash flow
- +2.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026